Stratipath和Roche伙伴分发AI驱动的乳腺癌诊断解决方案。 Stratipath and Roche partner to distribute AI-driven breast cancer diagnostics solution.

Stratipath和Roche合作,增加了乳腺癌患者获得AI驱动的精确诊断的机会。 Stratipath and Roche have partnered to enhance access to AI-driven precision diagnostics for breast cancer patients. Roche将分发Stratipath符合欧盟要求的解决方案—— " Stratipath 乳房 ",它利用AI评估乳腺癌组织的风险水平。 Roche will distribute Stratipath's EU-compliant solution, Stratipath Breast, which utilizes AI to assess risk levels in breast cancer tissue. 这一合作结合了罗什的导航数字病理学软件,简化了诊断程序,提供了比传统方法更快、成本效益更高的替代方法,最终改善了病人的护理。 This collaboration integrates with Roche's navify Digital Pathology software, streamlining diagnostics and offering a faster, more cost-effective alternative to traditional methods, ultimately improving patient care.